September 16, 2021 11:10 AM EDTUpdated 12:13 PM
Manufacturing

NeuEx­cell strikes deal with Fu­ji­film for stroke gene ther­a­py; J&J ex­pands in Ire­land

Josh Sullivan

In an ef­fort to ad­vance a gene ther­a­py to treat is­chemic cor­ti­cal stroke, Fu­ji­film Diosynth Biotech­nolo­gies and NeuEx­cell Ther­a­peu­tics have reached an

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA de­clines to ap­prove Ul­tragenyx's San­fil­ip­po gene ther­a­py, cit­ing man­u­fac­tur­ing is­sues

As­traZeneca posts a piv­otal tri­al win for blood pres­sure pill be­hind $1.3B deal

Take­da’s first-in-class nar­colep­sy drug suc­ceeds in two reg­is­tra­tional stud­ies

Bio­phar­ma's 20 high­est-paid CEOs of 2024 with $20M+ pay­days

Boehringer, LEO ink deal for IL-36 drug; Bay­er’s Keren­dia gets an­oth­er in­di­ca­tion

FDA's Makary calls for ty­ing fast-re­view vouch­ers to low­er US prices, with­out specifics

A service from the Financial Times